-
EP3294286
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3294286
| EP3294286 - DOCETAXEL AND HUMAN SERUM ALBUMIN COMPLEXES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.05.2021 Database last updated on 09.09.2024 | |
| Former | Examination is in progress Status updated on 28.08.2020 | ||
| Former | Request for examination was made Status updated on 16.02.2018 | ||
| Former | The international publication has been made Status updated on 25.11.2016 | Most recent event Tooltip | 11.05.2021 | Application deemed to be withdrawn | published on 09.06.2021 [2021/23] | Applicant(s) | For all designated states Albuvex LLC 18 Wilkinson Way Princeton, NJ 08540 / US | [2018/12] | Inventor(s) | 01 /
SUN, Qun 19 Aldgate Court Princeton, New Jersey 08540 / US | [2018/12] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [N/P] |
| Former [2018/12] | Kunz, Herbert Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | Application number, filing date | 16797113.4 | 16.05.2016 | [2018/12] | WO2016US32760 | Priority number, date | US201562162545P | 15.05.2015 Original published format: US 201562162545 P | US201562209053P | 24.08.2015 Original published format: US 201562209053 P | US201662299209P | 24.02.2016 Original published format: US 201662299209 P | [2018/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016187147 | Date: | 24.11.2016 | Language: | EN | [2016/47] | Type: | A1 Application with search report | No.: | EP3294286 | Date: | 21.03.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.11.2016 takes the place of the publication of the European patent application. | [2018/12] | Search report(s) | International search report - published on: | US | 24.11.2016 | (Supplementary) European search report - dispatched on: | EP | 05.12.2018 | Classification | IPC: | A61K31/337, A61K38/38 | [2018/12] | CPC: |
A61K31/337 (EP,CN,US);
A61K47/42 (EP,CN,US);
A61K9/0019 (EP,CN,US);
A61K9/08 (US);
A61K9/19 (EP,CN,US);
A61K9/5169 (EP);
A61P1/04 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P13/08 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P35/00 (EP,CN)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/12] | Title | German: | DOCETAXEL- UND HUMANSERUMALBUMIN-KOMPLEXE | [2018/12] | English: | DOCETAXEL AND HUMAN SERUM ALBUMIN COMPLEXES | [2018/12] | French: | COMPLEXES DE DOCÉTAXEL ET DE SÉRUMALBUMINE HUMAINE | [2018/12] | Entry into regional phase | 14.11.2017 | National basic fee paid | 14.11.2017 | Search fee paid | 14.11.2017 | Designation fee(s) paid | 14.11.2017 | Examination fee paid | Examination procedure | 14.11.2017 | Examination requested [2018/12] | 14.11.2017 | Date on which the examining division has become responsible | 01.07.2019 | Amendment by applicant (claims and/or description) | 01.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 12.01.2021 | Application deemed to be withdrawn, date of legal effect [2021/23] | 02.02.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/23] | Fees paid | Renewal fee | 29.05.2018 | Renewal fee patent year 03 | 28.05.2019 | Renewal fee patent year 04 | 27.05.2020 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2005282734 (KADIMA TENSHUK A [CA], et al) [X] 1-15* paragraphs [0061] , [0065] , [0077] , [0085] , [0086] , [0089]; example -; claim -; tables 3,6 * | International search | [XY]US2005282734 (KADIMA TENSHUK A [CA], et al) [X] 1-6, 56, 64-66 * entire document * [Y] 15-17, 26-29, 41-44, 57; | [A]US2010076008 (HEGEDUS LAJOS [HU], et al) [A] 1-6, 15-17, 26-29, 41-44, 56, 57, 64-66* entire document *; | [Y]US2012076862 (DESAI NEIL P [US], et al) [Y] 26-29, 41-44 * entire document *; | [Y]WO2014121033 (FL THERAPEUTICS LLC [US], et al) [Y] 15-17, 57 * entire document * |